Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.
D000818:Animals; D006027:Glycosides / Q000627:therapeutic use* / Q000633:toxicity; D007928:Lethal Dose 50; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D011034:Podophyllotoxin / Q000627:therapeutic use* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy*
D006027:Glycosides; D011034:Podophyllotoxin